著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Yukari Tsubata and Kana Watanabe and Ryota Saito and Atsushi Nakamura and Hiroshige Yoshioka and Mami Morita and Ryoichi Honda and Nobuhiro Kanaji and Satoshi Ohizumi and Daisuke Jingu and Taku Nakagawa and Kensuke Nakazawa and Atsuto Mouri and Susumu Takeuchi and Naoki Furuya and Yuki Akazawa and Kiyotaka Miura and Eiki Ichihara and Makoto Maemondo and Satoshi Morita and Kunihiko Kobayashi and Takeshi Isobe,Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B),International Journal of Clinical Oncology,1341-9625,Springer Science and Business Media LLC,2021-10-13,27,1,112-120,https://cir.nii.ac.jp/crid/1360013168860625280,https://doi.org/10.1007/s10147-021-02043-2